Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Understanding how the orbitofrontal cortex guides approach vs. avoidance in depression

Official title: Defining Orbitofrontal Circuit Function in Health and Depression

Run by University of California, San Francisco · NCT07896343 · Data updated 2026-11-12

This study tests how different parts of the orbitofrontal cortex influence whether people pursue rewards or risk loss, and whether this pattern is altered in Major Depressive Disorder.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedOctober 2026
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedOctober 27, 2026
Trial IDNCT07896343 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older with depression who have sEEG implants including OFC and are part of the PRESIDIO trial or undergoing related inpatient monitoring, plus suitable non-depressed controls with inpatient sEEG for other indications.

Probably not a fit

Patients without orbitofrontal cortex involvement in the implanted monitoring or without depressive symptoms may have limited direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will examine neural signals from depth electrodes implanted in the orbitofrontal cortex while participants perform an approach-avoidance decision task. The study compares individuals with major depressive disorder to non-depressed controls to see if medial OFC activity favors approach and lateral OFC activity favors avoidance, and whether depression shifts these signals. It leverages inpatient sEEG monitoring to directly measure brain activity during decision making related to potential rewards and losses. The findings aim to clarify brain mechanisms that contribute to reduced motivation in depression.

Why it matters

Potential benefit: Understanding OFC signaling could inform targeted approaches to improve motivation and decision making in depression.

How similar studies have gone: Prior work shows OFC involvement in reward and risk decisions, but this precise approach in depression with sEEG is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

All participants:

* 18 years of age or older
* Implanted with stereo-EEG (sEEG) depth electrodes, including at least one electrode in the orbitofrontal cortex (OFC)
* Able to read, write, and provide informed consent

Depressed cohort:

* Enrolled in the PRESIDIO trial (NCT04004169) of deep brain stimulation for treatment-resistant depression and undergoing inpatient sEEG monitoring as part of that trial
* Meets DSM-5 criteria for major depressive disorder (single episode of at least 2 years' duration, or recurrent), without psychotic features, confirmed by structured clinical interview (e.g., MINI)

Control (non-depressed) cohort:

* Undergoing inpatient sEEG monitoring for a clinical indication other than depression (e.g., seizure localization in refractory epilepsy)
* No current diagnosis of major depressive disorder, confirmed by clinical psychiatric evaluation (e.g., MINI and symptom scales)

Exclusion Criteria:

All participants:

* Current or past DSM-5 diagnosis of a psychotic disorder or major depressive disorder with psychotic features
* Current or past DSM-5 diagnosis of bipolar or related disorder
* Current obsessive-compulsive disorder
* Intellectual disability
* Autism spectrum disorder
* Borderline, antisocial, histrionic, or narcissistic personality disorder
* Impaired decision-making capacity or cognitive deficits that preclude informed consent or task completion
* Employee of the investigator or study site with direct involvement in the study, or family member of the investigator

Control (non-depressed) cohort only:

\* Epileptiform abnormalities involving the OFC, OFC dysplasia, or prior OFC resection, as determined by clinical evaluation and imaging

Where it's running

  • UCSF
    San Francisco, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.